Registry of Lobbyists

Registration - In-house Corporation

Solvay Pharma Inc. / Barry Hayter, President & Chief Excutive Officer

Registration Information

In-house Corporation name: Solvay Pharma Inc.
Responsible Officer Name: Barry Hayter, President & Chief Excutive Officer 
Responsible Officer Change History
Initial registration start date: 2006-09-25
Registration status: Inactive
Registration Number: 743414-13775

Associated Communications

Total Number of Communication Reports: 1

Monthly communication reports in the last 6 months: 0

Version 5 of 10 (2007-09-04 to 2008-04-08)

Version 5 of 10 (2007-09-04 to 2008-04-08) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: Solvay Pharma Inc.
102 - 60 Columbia Way
Markham, ON  L3R 0C9
Canada
Telephone number: 905-944-2480  Ext.: 203
Fax number: 905-944-2481  
Responsible officer name and position during the period of this registration: Graham Jobson, President & CEO  
Description of activities: The provision of innovative pharmaceutical products to the Canadian market
 
The client is a subsidiary of the following parent companies: Solvay S.A.
rue du Prince Albert 33
B-1050
Brussels
Belgium

Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Jim Smyth
Position title: Manager, Corporate Affairs
Public offices held: No
 
Name: Sean Webster
Position title: Vice President, Corporate Affairs
Public offices held: Yes
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Correctional Service of Canada (CSC), Health Canada (HC), Industry Canada, Members of the House of Commons, National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Royal Canadian Mounted Police (RCMP), Senate of Canada, Veterans Affairs Canada (VAC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Aboriginal Affairs, Defence, Government Procurement, Health, Industry, Intellectual Property, Science and Technology
 
Subject Matter: Retrospective: Discussions with government officials regarding the listing of innovative drug products on various federal government drug formularies.
Subject Matter: Prospective: Discussions with federal officials regarding the listing of innovative drug products on various federal government drug formularies.
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program DND Drug Formulary
Policy or Program National Pharmaceutical Strategy and Common Drug Review
Policy or Program Non-Insured Health Benefits Formulary




Date Modified: